Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neuroinflammation
Published in: Journal of Neuroinflammation 1/2012

Open Access 01-12-2012 | Research

A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption

Authors: Holly L Johnson, Yi Chen, Georgette L Suidan, Jeremiah R McDole, Anne K Lohrey, Lisa M Hanson, Fang Jin, Istvan Pirko, Aaron J Johnson

Published in: Journal of Neuroinflammation | Issue 1/2012

Login to get access

Abstract

Background

The extent to which susceptibility to brain hemorrhage is derived from blood-derived factors or stromal tissue remains largely unknown. We have developed an inducible model of CD8 T cell-initiated blood-brain barrier (BBB) disruption using a variation of the Theiler's murine encephalomyelitis virus (TMEV) model of multiple sclerosis. This peptide-induced fatal syndrome (PIFS) model results in severe central nervous system (CNS) vascular permeability and death in the C57BL/6 mouse strain, but not in the 129 SvIm mouse strain, despite the two strains' having indistinguishable CD8 T-cell responses. Therefore, we hypothesize that hematopoietic factors contribute to susceptibility to brain hemorrhage, CNS vascular permeability and death following induction of PIFS.

Methods

PIFS was induced by intravenous injection of VP2121-130 peptide at 7 days post-TMEV infection. We then investigated brain inflammation, astrocyte activation, vascular permeability, functional deficit and microhemorrhage formation using T2*-weighted magnetic resonance imaging (MRI) in C57BL/6 and 129 SvIm mice. To investigate the contribution of hematopoietic cells in this model, hemorrhage-resistant 129 SvIm mice were reconstituted with C57BL/6 or autologous 129 SvIm bone marrow. Gadolinium-enhanced, T1-weighted MRI was used to visualize the extent of CNS vascular permeability after bone marrow transfer.

Results

C57BL/6 and 129 SvIm mice had similar inflammation in the CNS during acute infection. After administration of VP2121-130 peptide, however, C57BL/6 mice had increased astrocyte activation, CNS vascular permeability, microhemorrhage formation and functional deficits compared to 129 SvIm mice. The 129 SvIm mice reconstituted with C57BL/6 but not autologous bone marrow had increased microhemorrhage formation as measured by T2*-weighted MRI, exhibited a profound increase in CNS vascular permeability as measured by three-dimensional volumetric analysis of gadolinium-enhanced, T1-weighted MRI, and became moribund in this model system.

Conclusion

C57BL/6 mice are highly susceptible to microhemorrhage formation, severe CNS vascular permeability and morbidity compared to the 129 SvIm mouse. This susceptibility is transferable with the bone marrow compartment, demonstrating that hematopoietic factors are responsible for the onset of brain microhemorrhage and vascular permeability in immune-mediated fatal BBB disruption.
Literature
1.
Zlokovic BV: The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178–201.CrossRefPubMed
2.
Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ: Neurological manifestations of dengue infection. Lancet 2000, 355:1053–1059.CrossRefPubMed
3.
Janssen HL, Bienfait HP, Jansen CL, van Duinen SG, Vriesendorp R, Schimsheimer RJ, Groen J, Osterhaus AD: Fatal cerebral oedema associated with primary dengue infection. J Infect 1998, 36:344–346.CrossRefPubMed
4.
Pancharoen C, Mekmullica J, Thisyakorn U: Primary dengue infection: what are the clinical distinctions from secondary infection? Southeast Asian J Trop Med Public Health 2001, 32:476–480.PubMed
5.
George R, Lam SK: Dengue virus infection: the Malaysian experience. Ann Acad Med Singapore 1997, 26:815–819.PubMed
6.
Shacklett BL, Cox CA, Wilkens DT, Karlsson KR, Nilsson A, Nixon DF, Price RW: Increased adhesion molecule and chemokine receptor expression on CD8 + T cells trafficking to cerebrospinal fluid in HIV-1 infection. J Infect Dis 2004, 189:2202–2212.CrossRefPubMed
7.
Minagar A, Alexander JS: Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003, 9:540–549.CrossRefPubMed
8.
Kirk J, Plumb J, Mirakhur M, McQuaid S: Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 2003, 201:319–327.CrossRefPubMed
9.
Plumb J, McQuaid S, Mirakhur M, Kirk J: Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 2002, 12:154–169.CrossRef
10.
Stone LA, Smith ME, Albert PS, Bash CN, Maloni H, Frank JA, McFarland HF: Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology 1995, 45:1122–1126.CrossRefPubMed
11.
Green R, Scott LK, Minagar A, Conrad S: Sepsis associated encephalopathy (SAE): a review. Front Biosci 2004, 9:1637–1641.CrossRefPubMed
12.
Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Françoise G: The neuropathology of septic shock. Brain Pathol 2004, 14:21–33.CrossRefPubMed
13.
Medana IM, Turner GD: Human cerebral malaria and the blood-brain barrier. Int J Parasitol 2006, 36:555–568.CrossRefPubMed
14.
Gibbs WN, Kreidie MA, Kim RC, Hasso AN: Acute hemorrhagic leukoencephalitis: neuroimaging features and neuropathologic diagnosis. J Comput Assist Tomogr 2005, 29:689–693.CrossRefPubMed
15.
16.
Lacerda-Queiroz N, Rodrigues DH, Vilela MC, Rachid MA, Soriani FM, Sousa LP, Campos RD, Quesniaux VF, Teixeira MM, Teixeira AL: Platelet-activating factor receptor is essential for the development of experimental cerebral malaria. Am J Pathol 2012, 180:246–255.CrossRefPubMed
17.
de Vries NA, Beijnen JH, Boogerd W, van Tellingen O: Blood-brain barrier and chemotherapeutic treatment of brain tumors. Expert Rev Neurother 2006, 6:1199–1209.CrossRefPubMed
18.
Blamire AM, Anthony DC, Rajagopalan B, Sibson NR, Perry VH, Styles P: Interleukin-1β-induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. J Neurosci 2000, 20:8153–8159.
19.
Stoll G, Jander S, Schroeter M: Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J Neural Transm Suppl 2000, 59:81–89.PubMed
20.
Chavarria A, Alcocer-Varela J: Is damage in central nervous system due to inflammation? Autoimmun Rev 2004, 3:251–260.CrossRefPubMed
21.
Kim JV, Kang SS, Dustin ML, McGavern DB: Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 2009, 457:191–195.CrossRefPubMed
22.
Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A: Human T H 17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007, 13:1173–1175.CrossRefPubMed
23.
Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR: VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 2009, 106:1977–1982.CrossRefPubMedPubMedCentral
24.
Suidan GL, McDole JR, Chen Y, Pirko I, Johnson AJ: Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One 2008, 3:e3037.CrossRefPubMedPubMedCentral
25.
Suidan GL, Dickerson JW, Chen Y, McDole JR, Tripathi P, Pirko I, Seroogy KB, Johnson AJ: CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J Immunol 2010, 184:1031–1040.CrossRefPubMed
26.
27.
Johnson AJ, Mendez-Fernandez Y, Moyer AM, Sloma CR, Pirko I, Block MS, Rodriguez M, Pease LR: Antigen-specific CD8 + T cells mediate a peptide-induced fatal syndrome. J Immunol 2005, 174:6854–6862.CrossRefPubMed
28.
Loke H, Bethell DB, Phuong CX, Dung M, Schneider J, White NJ, Day NP, Farrar J, Hill AV: Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis 2001, 184:1369–1373.CrossRefPubMed
29.
Zivna I, Green S, Vaughn DW, Kalayanarooj S, Stephens HA, Chandanayingyong D, Nisalak A, Ennis FA, Rothman AL: T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol 2002, 168:5959–5965.CrossRefPubMed
30.
Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT, McMichael A, Malasit P, Screaton G: Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003, 9:921–927.CrossRefPubMed
31.
Green S, Pichyangkul S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Nisalak A, Kurane I, Rothman AL, Ennis FA: Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis 1999, 180:1429–1435.CrossRefPubMed
32.
Stephens HA, Klaythong R, Sirikong M, Vaughn DW, Green S, Kalayanarooj S, Endy TP, Libraty DH, Nisalak A, Innis BL, Rothman AL, Ennis FA, Chandanayingyong D: HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002, 60:309–318.CrossRefPubMed
33.
Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA: Activation of T lymphocytes in dengue virus infections: high levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-γ in sera of children with dengue. J Clin Invest 1991, 88:1473–1480.CrossRefPubMedPubMedCentral
34.
Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K, Wekerle H, Hohlfeld R, Goebels N: Multiple sclerosis: brain-infiltrating CD8 + T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci USA 2004, 101:2428–2433.CrossRefPubMedPubMedCentral
35.
Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schröder R, Deckert M, Schmidt S, Ravid R, Rajewsky K: Clonal expansions of CD8 + T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000, 192:393–404.CrossRefPubMedPubMedCentral
36.
Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen L, Rodriguez M, Pease LR: Prevalent class I-restricted T-cell response to the Theiler's virus epitope D b :VP2 121–130 in the absence of endogenous CD4 help, tumor necrosis factor α, γ interferon, perforin, or costimulation through CD28. J Virol 1999, 73:3702–3708.PubMedPubMedCentral
37.
Lin X, Thiemann NR, Pease LR, Rodriguez M: VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 1995, 214:91–99.CrossRef
38.
McDole JR, Danzer SC, Pun RY, Chen Y, Johnson HL, Pirko I, Johnson AJ: Rapid formation of extended processes and engagement of Theiler's virus-infected neurons by CNS-infiltrating CD8 T cells. Am J Pathol 2010, 177:1823–1833.CrossRefPubMedPubMedCentral
39.
Johnson AJ, Upshaw J, Pavelko KD, Rodriguez M, Pease LR: Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection. FASEB J 2001, 15:2760–2762.PubMed
40.
Kovacevic N, Henderson JT, Chan E, Lifshitz N, Bishop J, Evans AC, Henkelman RM, Chen XJ: A three-dimensional MRI atlas of the mouse brain with estimates of the average and variability. Cereb Cortex 2005, 15:639–645.CrossRefPubMed
41.
42.
Pirko I, Gamez J, Johnson AJ, Macura SI, Rodriguez M: Dynamics of MRI lesion development in an animal model of viral-induced acute progressive CNS demyelination. Neuroimage 2004, 21:576–582.CrossRefPubMed
43.
Pirko I, Johnson AJ, Chen Y, Lindquist DM, Lohrey AK, Ying J, Dunn RS: Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage 2011, 54:802–806.CrossRefPubMed
44.
Pirko I, Nolan TK, Holland SK, Johnson AJ: Multiple sclerosis: pathogenesis and MR imaging features of T1 hypointensities in a murine model. Radiology 2008, 246:790–795. A published erratum appears in Radiology 2008, 248:322CrossRefPubMed
45.
46.
Robb RA: The biomedical imaging resource at Mayo Clinic. IEEE Trans Med Imaging 2001, 20:854–867.CrossRefPubMed
47.
Rubin P, Gash DM, Hansen JT, Nelson DF, Williams JP: Disruption of the blood-brain barrier as the primary effect of CNS irradiation. Radiother Oncol 1994, 31:51–60.CrossRefPubMed
48.
van Vulpen M, Kal HB, Taphoorn MJB, El Sharouni SY: Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? Oncol Rep 2002, 9:683–688.PubMed
49.
Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR, Hendricks RL: Noncytotoxic lytic granule-mediated CD8 + T cell inhibition of HSV-1 reactivation from neuronal latency. Science 2008, 322:268–271.CrossRefPubMedPubMedCentral
50.
Smyth MJ, Kelly JM, Sutton VR, Davis JE, Browne KA, Sayers TJ, Trapani JA: Unlocking the secrets of cytotoxic granule proteins. J Leukoc Biol 2001, 70:18–29.PubMed
51.
Weis SM, Cheresh DA: Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005, 437:497–504.CrossRefPubMed
52.
Baluna R, Vitetta ES: Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology 1997, 37:117–132.CrossRefPubMed
53.
Engelhardt B: Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm 2006, 113:477–485.CrossRefPubMed
54.
Jin R, Yang G, Li G: Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis 2010, 38:376–385.CrossRefPubMedPubMedCentral
55.
Wosik K, Biernacki K, Khouzam MP, Prat A: Death receptor expression and function at the human blood brain barrier. J Neurol Sci 2007, 259:53–60.CrossRefPubMed
Metadata
Title
A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption
Authors
Holly L Johnson
Yi Chen
Georgette L Suidan
Jeremiah R McDole
Anne K Lohrey
Lisa M Hanson
Fang Jin
Istvan Pirko
Aaron J Johnson
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2012
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-9-60

Other articles of this Issue 1/2012

Journal of Neuroinflammation 1/2012 Go to the issue

Research

Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice

Research

Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia

Research

Adenosine A2B receptor-mediated leukemia inhibitory factor release from astrocytes protects cortical neurons against excitotoxicity

Research

Morphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal model

Research

GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia

Research

GLP-1 secretion by microglial cells and decreased CNS expression in obesity